ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,448Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 384

$800K Total Retail Price of All Prescriptions

Rank: 15 out of 384

766 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
0% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 16,077 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SYNTHROID 2,256 1,886 1 9
SIMVASTATIN 1,799 1,629 2 1
METFORMIN HCL 999 871 3 2
LOSARTAN-HYDROCHLOROTHIAZIDE 869 806 4 10
AMLODIPINE BESYLATE 760 674 5 3
HYDROCHLOROTHIAZIDE 560 491 6 16
GABAPENTIN 469 393 7 4
LISINOPRIL 404 357 8 14
ENALAPRIL MALEATE 380 318 9 6
OMEPRAZOLE 361 327 10 8
METOPROLOL SUCCINATE 354 304 11 21
LOSARTAN POTASSIUM 305 267 12 5
METOPROLOL TARTRATE 303 258 13 15
GLIMEPIRIDE 273 241 14 18
HUMALOG MIX 75-25 270 215 15 104
RAMIPRIL 257 246 16 51
ALENDRONATE SODIUM 256 230 17 20
HUMULIN 70-30 255 225 18 47
GLYBURIDE-METFORMIN HCL 250 234 R 19 64
RANITIDINE HCL 189 156 20 7
LEVOTHYROXINE SODIUM 187 162 21 11
ZOLPIDEM TARTRATE 179 161 22 19
AMLODIPINE BESYLATE-BENAZEPRIL 166 138 23 43
PANTOPRAZOLE SODIUM 158 151 24 39
LANTUS 158 140 24 42
DOXAZOSIN MESYLATE 157 153 26 29
VYTORIN 155 136 27 99
FUROSEMIDE 152 125 28 17
ATENOLOL 148 140 29 12
ATORVASTATIN CALCIUM 144 113 30 22
CLOPIDOGREL 138 115 31 30
SERTRALINE HCL 138 115 31 26
EVISTA 136 121 33 52
HUMALOG 127 106 34 158
PLAVIX 122 111 35 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 121 119 36 78
TRICOR 115 80 37 123
CARVEDILOL 112 105 38 23
JANUVIA 103 89 39 108
IRBESARTAN 101 71 40 55
ISOSORBIDE MONONITRATE ER 98 93 41 28
GLIPIZIDE XL 92 92 42 115
INSULIN SYRINGE 82 62 43 46
GEMFIBROZIL 80 70 44 74
HUMULIN N 80 64 44 57
JANUMET 79 70 46 116
QUINAPRIL HCL 71 63 47 110
DIOVAN 70 63 48 54
GLIPIZIDE ER 69 59 49 105
LEVOXYL 69 60 49 44
ASPIRIN EC 68 47 51 31
VERAPAMIL ER 68 65 51 41
DIOVAN HCT 66 62 53 66
CRESTOR 65 47 54 45
HUMALOG MIX 50-50 65 20 54 261
INDAPAMIDE 62 62 56 152
NOVOLOG MIX 70-30 61 52 57 252
TAMSULOSIN HCL 59 55 58 25
VITAMIN D 58 51 59 239
LYRICA 58 28 59 92
GLIPIZIDE 56 54 61 27
ENALAPRIL-HYDROCHLOROTHIAZIDE 56 46 61 134
DIGOXIN 55 54 63 49
ATACAND HCT 55 50 63 318
ZETIA 55 51 63 69
LANSOPRAZOLE 53 52 66 86
AVAPRO 53 47 66 87
DILTIAZEM 24HR CD 53 53 66 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.